Beth C. Seidenberg - May 15, 2024 Form 4 Insider Report for Vera Therapeutics, Inc. (VERA)

Role: Director
Signature: /s/ Joseph R. Young, Attorney-in-Fact
Stock symbol: VERA
Transactions as of: May 15, 2024
Transactions value $: $0
Form type: 4
Date filed: 5/17/2024, 04:17 PM
Previous filing: Feb 14, 2024
Next filing: May 28, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	VERA	Stock Option (right to buy)	Award	$0	+14K		$0.00	14K	May 15, 2024	Class A Common Stock	14K	$42.69	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The shares subject to the option will vest in full on the earlier of the first anniversary of the grant date or the date of the Company's 2025 annual stockholder meeting, subject to the Reporting Person's continuous service through such vesting date. Notwithstanding the foregoing, the shares will vest in full upon a change in control, subject to the Reporting Person's continuous service through the date of such change in control.

Content

The shares subject to the option will vest in full on the earlier of the first anniversary of the grant date or the date of the Company's 2025 annual stockholder meeting, subject to the Reporting Person's continuous service through such vesting date. Notwithstanding the foregoing, the shares will vest in full upon a change in control, subject to the Reporting Person's continuous service through the date of such change in control.